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ABSTRACT 
 
 
Injection drug users (IDUs) represent a significant vector for contracting and 
transmission of HIV infection, which occurs through preventable drug- and sex-related 
risk behaviors. Accordingly, IDUs remain a target population of HIV risk reduction 
behavioral interventions. Previous findings show that it is feasible to provide a brief 
behavioral risk reduction group intervention to high risk HIV-infected IDUs in a 
community-based setting to reduce HIV risk-related outcomes. In order for behavioral 
interventions to be effective, a relatively high level of cognitive abilities is required. 
Evidence shows that chronic drug use can affect the central nervous system and this may 
result in neurocognitive impairment that could potentially interfere with optimal 
participation in such behavioral interventions. Few efforts have been made to determine 
how neurocognitive impairment may negatively impact intervention participation and, in 
turn, outcomes in this population. In this study high-risk HIV-negative opioid-dependent 
drug users seeking drug treatment in a community based methadone program received 4-
session of Community-Friendly Health Recovery Program (CHRP) vs. a Control 
condition to evaluate whether there is a significant association between cognitive 
impairment and HIV risk reduction intervention outcomes. 
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INTRODUCTION 
 There are currently over 1 million people living with HIV/AIDS in United 
States U.S. and, 20% of those people are unaware of their infection (Center for Disease 
Control and Prevention [CDC], 2008). HIV infection is caused by Human 
Immunodeficiency Virus. This virus can gradually destroy the immune system and lead 
to Acquired Immune Deficiency Syndrome (AIDS). HIV is transmitted via body fluids 
including blood, semen, vaginal fluid, and breast milk. The most common routs of HIV 
transmission are: unprotected sex and sharing needles, syringes, rinse water, or other 
unsterilized injection equipment. HIV transmission via birth, breastfeeding, and blood 
transfusion is not a main concern in U.S. anymore although it is still a key route of 
transmission in many developing countries. In the U.S., men who have sex with men 
(MSM), heterosexual intercourse, and injection drug use (IDU) are the major modes of 
HIV transmission (see Figure below). 
  
Figure1. Estimated New HIV Infection by Transmission Category (CDC, 2010)  
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Despite a range of HIV prevention efforts, CDC estimated, HIV incidence 
was approximately 48,100 new HIV infections in the United States in 2009 (CDC, 2009). 
About 8% of these new HIV infections in 2010 occurred among injecting drug users 
(IDUs; CDC, 2010). People who have unprotected sex with an injection drug user also 
are at risk of infection through the sexual transmission of HIV. Trading sex for money or 
for drugs are also activities that put drug dependent individuals at risk for contracting or 
transmitting HIV (CDC, 2009).  
In 2000, 11635 AIDS cases in U.S. were evaluated regarding their route of 
HIV contraction and the results showed that 73% of AIDS cases were directly associated 
with IDU while, the 27% of AIDS cases were indirectly associated with IDU and were 
seen among sex partners of IDUs, male-IDUs who had sex with men and children of 
IDUs or their sex partners (see Figure below). 
  
Figure2. Proportion of IDU associated AIDS cases, by exposure category in 2000, United States. 
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Studies have shown that substance abusers tend to practice HIV-related risk 
behaviors such as sharing needles or having unprotected sex especially while under the 
influence of drugs (National Institute on Drug Abuse [NIDA], 2012). 
 There is currently no effective vaccine to prevent new HIV infections while 
previous studies show that through behavioral interventions, risky sexual and needle 
sharing behaviors can be effectively reduced. Maintaining consistently safe sex- and 
drug-behaviors over time and increasing knowledge of HIV status and personal risk 
factors through behavioral interventions could eliminate the high risk of HIV 
transmission among populations at risk. Accordingly, behavioral interventions remain a 
primary tool for reducing the risk of HIV transmission (Semaan et al., 2002). There are 
some evidence-based behavioral intervention approaches targeting HIV-infected and 
HIV-negative IDUs (Holistic Health Recovery Program-HHRP+). The goal of these 
approaches is to improve antiretroviral medication adherence and reduce HIV 
transmission risk for HIV-infected patients and reduce HIV risk behaviors for high risk 
HIV-negative patients (Avants, Margolin, Usubiaga, & Doebrick, 2004; Margolin, 
Avants, Warburton, Hawkins, & Shi, 2003). These interventions consist of a series of 
group ‘treatment’ sessions, where HIV-infected participants are provided information on 
antiretroviral medication adherence, risk behaviors, and how to maximize their outcomes. 
Participants are also taught harm reduction skills, such as how to properly use condoms 
and how to sterilize needles (Avants et al., 2004; Margolin et al., 2003). 
Evidence shows that these behavioral interventions are also applicable in 
community based organizations that offer OAT (opioid agonist therapy) for drug 
dependent patients (M. M. Copenhaver, Lee, & Margolin, 2007). OAT -a type of drug 
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abuse treatment- is also an effective intervention used as HIV prevention. The goal of 
OAT is to reduce illicit drug use and consequently to limit exposure to needle sharing and 
to increase the practice of safer sex among IDUs. Methadone maintenance therapy 
(MMT) is the most widely applied and researched OAT. Methadone blocks the euphoric 
effects of other opioids and evidence shows that MMT has been effective in reducing 
illicit opioid use (Metzger & Zhang, 2010). 
On the other hand, both chronic drug abuse and OAT exacerbate 
neurocognitive impairment (NCI) which can lead to HIV risk-taking behaviors and also 
could reduce the effectiveness of risk reduction behavioral interventions (Anand, 
Springer, Copenhaver, & Altice, 2010). Most drugs of abuse cross the blood-brain-barrier 
and directly affect the central nervous system (CNS), resulting in NCI symptoms 
(Tamrazi & Almast, 2012). Deficits in attention, working memory, episodic memory, and 
executive function have been observed in individuals with drug abuse (Rapeli et al., 
2006). NCI symptoms can range from very mild to very severe, and studies suggest that 
symptoms tend to worsen with prolonged drug use (Heaton et al., 1995). 
 In order to be effective, risk-reduction interventions must therefore take into 
account the impact of on learning and behavior. Some interventions use cognitive 
remediation strategies that are designed to take into account the possibility of NCI in the 
target populations and accordingly consider the specific intervention needs of drug users 
with NCI (M. Copenhaver, Avants, Warburton, & Margolin, 2003). Based on these 
findings, access to proven risk reduction behavioral interventions, and also continued 
research activities to develop optimal interventions suitable for high-risk population in 
the U.S. is highly recommended.  The purpose of the current study was to examine the 
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relationship between NCI and HIV risk reduction intervention outcomes in a sample of 
high-risk HIV-negative drug-dependent patients seeking drug treatment in a community 
based methadone program. The participants participated in a Community-Friendly Health 
Recovery Program (CHRP) for HIV-negative drug users in New Haven, Connecticut. 
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LITERATURE REVIEW 
Drug dependence and HIV/AIDS are still major public health problems in the 
U.S. and many other parts of the world. According to the 4
th
 edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) substance abuse is defined as having 
problems at work, home, and school; problems with family or friends; physical danger; 
and trouble with the law due to substance use while the dependence status is defined as 
health and emotional problems, attempts to cut down on use, tolerance, withdrawal, and 
other symptoms associated with substances use (American Psychological Association, 
1994). The National Institute on Drug Abuse (NIDA) lists 10 different categories for 
drugs of abuse including: legal recreational substances (e.g. alcohol), prescription 
medications (e.g. opioids), and illegal substances (e.g. heroin, cocaine and marijuana; 
NIDA, 2011). According to Substance Abuse and Mental Health services 
Administration’s (SAMHSA) 2011 estimate of substance dependence or abuse in the past 
year, 20.6 million persons (8% of the population aged 12 or older) were classified with 
substance dependence or abuse based on criteria specified in DSM-IV. Of these, 2.6 
million were classified with dependence or abuse of both alcohol and illicit drugs and 3.9 
million had dependence or abuse of illicit drugs but not alcohol. According to 
SAMHSA’s 2011 survey, the rate of current illicit drug use (one month prior to survey) 
generally declined with age and was higher for males. Among persons aged 12 or older, 
the rate of current illicit drug use was lowest among Asians followed by Hispanics, 
whites, blacks, Native Hawaiians or Other Pacific Islanders, American Indians or Alaska 
Natives. Among adults aged 18 or older, the rate of current illicit drug use was positively 
associated with unemployment and negatively associated with the level of education. 
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Among persons aged 12 or older, the rate of current illicit drug use in 2011 was highest in 
the West followed by the Northeast, Midwest and South of the US (SAMHSA, 2011). 
The fact is that drug abuse or drug dependence is associated with significant morbidity 
and mortality. For example, IDU can increase the risk of infection through needle 
contamination with HIV, hepatitis, and other organisms.  
 It is estimated that 34.2 million people were living with HIV in 2011 
worldwide. East and Southern Africa remains the area most heavily affected by the HIV 
epidemic (UNAIDS, 2011). HIV is transmitted through six common categories including 
male-to-male sexual contact, IDU, male-to-male sexual contact and IDU, heterosexual 
contact, mother-to-child (perinatal) transmission, and other (like blood transfusions and 
unknown cause). IDU is a major risk factor of HIV transmission or contraction. In 2010, 
IDU was the third most frequently reported risk factor for HIV infection in the U.S. 
(CDC, 2010). In Northeastern United States, as many as 44% of all new HIV infections 
are directly or indirectly attributable to drug use (CDC, 2009). In 2010, IDUs and male 
who have sex with male (MSM) and are IDUs accounted for approximately 8% and 3% 
of all the new cases of HIV infection. According to the CDC in the same year, MSM 
accounted for 61% and heterosexual intercourse accounted for 28% of new HIV 
infections. The highest rates of people living with a diagnosis of HIV infection at the end 
of 2008, was reported in the South and the Northeast of the U.S. In 2009, African 
Americans accounted for 44% of all new HIV infections in the U.S. while they represent 
only 14% of the U.S. population (CDC, 2009). 
                  The impact that drug use and abuse can have on the spread of HIV/AIDS is 
not only through IDU and needle sharing but also through the risky behaviors that occur 
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in the context of drug use. Drug intoxication affects mental status and judgment and can 
lead to risky sexual behavior (e.g. unprotected sex or having multiple sex partners) that 
puts participants at risk of contracting or transmitting HIV and other sexually transmitted 
diseases. Moreover, substance use can weaken the immune system and consequently 
facilitate the progress of HIV infection. Substance abuse is one of the focus areas of 
Healthy People 2020 and one of the proposed objectives of Healthy People 2020 is: 
‘increase the number of admission to substance abuse treatment for injection drug use’. 
Co-occurring of HIV and substance abuse is also mentioned in one of the proposed 
objectives: ‘increase the proportion of substance abuse treatment facilities that offer 
HIV/AIDS education, counseling, and support’. 
With such a significant number of HIV cases directly or indirectly related to 
drug use, effective substance abuse treatment and HIV-prevention interventions should 
be delivered to this high risk population. NIDA's research has showed that 
comprehensive HIV prevention including substance abuse treatment and community-
based outreach, in combination with testing and counseling for HIV and other infections 
is an effective approach (NIDA, 2005). Drug abuse and HIV/AIDS are related issues and 
based on this fact, drug treatment becomes a crucial HIV prevention method while it 
limits exposure to needle sharing and increases the practice of safer sex. Most of the drug 
involved people, are poly-drug users (users of more than one drug) and will require 
treatment for all of the substances that they abuse. Detoxification of drugs is also 
accompanied by withdrawal syndrome, which is managed with medications prescribed by 
a physician in an inpatient or outpatient setting. Medications are used to prevent relapse 
and decrease cravings and also help reestablish normal brain function. Different types of 
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medications are applied to control the withdrawal symptoms such as opioids, 
benzodiazepines, alcohol, nicotine, barbiturates, and other sedatives (NIDA, 2012). 
Opioid agonist therapy (OAT) is one of the substance abuse treatments 
applied to reduce illicit drug use. OAT is defined as the consumption of regular, 
controlled doses of opioid agonists for extended periods (e.g. > 6 months). Methadone, 
buprenorphine and, for some individuals, naltrexone are effective medications for the 
treatment of opiate addiction. Methadone maintenance therapy (MMT) is the most widely 
applied and researched OAT. Methadone is used orally and blocks the euphoric effects of 
other opioids. Its metabolism is slow, lasts longer than many illicit opioids, and is 
acceptable to many patients (Metzger & Zhang, 2010). Evidence shows that MMT has 
been effective in reducing illicit opioid use and has helped patients disengage from drug 
seeking and related criminal behavior and become more receptive to behavioral 
treatments (NIDA, 2009). 
Neurocognitive impairment among drug involved population:  
Most drugs of abuse cross the blood-brain-barrier and directly affect the 
central nervous system (CNS), resulting in Neurocognitive impairment (NCI) symptoms. 
There are different types of substances with serious brain complications including 
cocaine, heroin, alcohol, amphetamines, toluene, and cannabis. The CNS complications 
of these drugs include neurovascular complications, encephalopathy, atrophy, infection 
and other changes in brain structure (Tamrazi & Almast, 2012). Deficits in attention, 
working memory, episodic memory, and executive function have been observed in 
individuals with drug abuse (Rapeli et al., 2006). Previous studies indicate that there is an 
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extensive overlap between the brain regions and neural processes that underlie addiction 
and those that support cognitive functions like learning, memory, and reasoning. On the 
other hand, cognitive deficits followed by continued drug use exacerbate the difficulty of 
establishing sustained abstinence.  The developing brain is particularly susceptible to the 
effects of drugs of abuse; accordingly, prenatal, childhood, and adolescent exposures 
produce long-lasting changes in cognition (Gould, 2010). Some studies suggest that the 
association between chronic drug use and different types of cognitive deficit may be 
because of the direct impact of specific drugs on brain or because of impact of drugs on 
deficits that have already happened and could possibly make that person susceptible to 
the effects of drug abuse (Ersche, Clark, London, Robbins, & Sahakian, 2006). 
Neuroimaging studies suggest that methamphetamines can make changes in serotonin 
and dopamine function and also can make difference in cerebral blood flow. These 
studies suggest that methamphetamine use is associated with mood and anxiety disorders, 
psychosis, and cognitive deficits. Changes in inhibitory control -one of the domains of 
cognitive function- caused by methamphetamine use are associated with continued use of 
this substance and high tendency to relapse (Price et al., 2011). Methamphetamine users 
experience generalized difficulties with prospective memory even after abstinence 
(Rendell, Mazur, & Henry, 2009). Other studies indicate that long-term heavy cannabis 
use can result in memory impairment in adults. The results also show that even brief 
exposure to cannabis adversely affects the developing brain of adolescents, as this 
population demonstrates memory deficits similar to those reported in adult long-term 
heavy users (Solowij et al., 2011). Le Berre et al. showed that in their sample of chronic 
alcoholics both episodic memory and metamemory for novel information has been 
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affected. Executive dysfunction was also seen in this clinical population (Le Berre et al., 
2010).  In one study 19 recently abstinent cocaine-dependent males were compared to 16 
control subjects on a battery of neuropsychological tests. The results showed that the 
performance of cocaine-dependent subjects was inferior to the control group on tasks 
assessing higher level verbal skills, and on a task requiring logical sequencing of complex 
visual stimuli. Cocaine users also performed poorly on a delayed visual memory task and 
on a verbal generation task, but performed better than the control group on a task 
assessing simple visual-motor speed (Gillen et al., 1998). One study estimated the 
prevalence of NCI in different components of executive functions in poly-substance users 
who were enrolled in therapeutic communities. Study results showed a significant 
prevalence of executive function impairment in poly-substance users compared to non-
substance users. Working memory was the component with the highest impairment 
proportion, followed by fluency, shifting, planning, multi-tasking and interference 
(Fernandez-Serrano, Perez-Garcia, Perales, & Verdejo-Garcia, 2010). In St. Petersburg, 
Russia a group of Heroin addicts were compared with three comparison groups including 
alcoholics, addicts who used both alcohol and heroin, and non-abusers. The results 
showed that heroin addicts exhibited significantly more disadvantageous decision making 
and longer deliberation times while making risky decisions compared to other groups 
(Fishbein et al., 2007).  Some studies indicated that heroin addicts with history of poly-
drug abuse perform worse than controls but better than amphetamine users on functions 
like: impulsivity, attention and learning, working memory and pattern recognition 
(Ersche et al., 2006; Ornstein et al., 2000). 
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There are other common issues among drug involved patients which are 
associated with NCI, such as; drug-related infections (e.g. HIV and Hepatitis C viral 
infection), traumatic brain injury, and mental illness, and opioid substitution therapy. 
Studies have shown that following HIV infection, cognitive performance (such as 
learning of new information, information processing speed and attention) and daily 
functioning are highly affected (Anand et al., 2010). Among HIV-associated CNS 
disorders, HIV-associated neurocognitive disorders (HAND), is the most significant one 
(Boisse, Gill, & Power, 2008). Evidence shows that brain injury acquired during 
advanced immune suppression might be only partially reversible with antiretroviral 
therapy (Letendre, Ellis, Ances, & McCutchan, 2010). Moreover, opioid dependence can 
reduce immune system integrity and stimulate viral replication in HIV-seropositive drug 
users and consequently exacerbate HAND (Anand et al., 2010). Studies show that 
patients with mental illness are also at high risk for substance abuse, and the adverse 
impact of drug abuse on cognition may be particularly deleterious in combination with 
cognitive problems related to their mental disorders (Gould, 2010). Findings show that 
OAT is also associated with NCI (Anand et al., 2010). Some psychomotor and cognitive 
dysfunctions have been seen in methadone-maintained patients compared to matched 
control groups (Darke, Sims, McDonald, & Wickes, 2000). Some studies indicate that 
abstinence from certain drug groups may cause some cognitive improvements (Ersche et 
al., 2006; Papageorgiou et al., 2004; Verdejo, Toribio, Orozco, Puente, & Perez-Garcia, 
2005). However, one study comparing methadone-maintained patients with current 
cocaine dependence to methadone-maintained abstainers shows no differences on 
measures of cognitive functions between these two groups (Henry et al., 2012). Previous 
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studies indicate that NCI symptoms tend to worsen with prolonged drug use (Heaton et 
al., 1995). Drug dependence and drug induced NCI could both affect the quality of life, 
and possibly the craving and relapse. NIDA has estimated that in 2002 illicit drug use 
alone has accounted for $181 billion in health care, productivity loss, crime, incarceration 
and drug enforcement office (Office of National Drug Control Policy, 2004).  
Substance abuse and HIV related risk behaviors:                  
Evidence shows that the NCI due to substance abuse is associated with 
increased HIV related risk behaviors, which are caused by drug-induced poor judgment. 
NCI due to substance abuse is also associated with significant barriers to HIV risk 
reduction behavioral interventions which also cause the increased HIV related risk 
behaviors (Avants, Warburton, Hawkins, & Margolin, 2000). Studies have shown that 
drug dependent people are involved in sex- and drug-related HIV risk behaviors more 
than other people. Epidemiological studies have identified multi-person use of 
contaminated drug injection equipment, such as needles and syringes as a major route for 
transmitting HIV among IDUs (Needle et al., 1998). The results of one study evaluating 
2091 IDUs in the capitals of 29 provinces in Iran showed that 35.8% of sample reported 
lifetime experience of needle and syringe sharing (Rafiey et al., 2009). In Pakistan in a 
sample of 161 IDUs, sharing syringes was reported by 79.5% of participants (Altaf et al., 
2007). In another study 54 drug injection networks were observed by researchers in seven 
cities of seven different states of the U.S. Sharing injection paraphernalia or drug solution 
occurred in 94% of injection events and serial use of syringes or needles occurred in 14% 
of events. While, reuse of cookers, cotton and water respectively occurred in 84%, 77% 
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and 77% of events (Needle et al., 1998). Besides, generalization of the HIV epidemic 
from high-risk groups to the general population may be driven by risky sexual behavior 
among drug users. One study has examined the role of risky sexual behaviors on HIV 
infection among 426 IDUs and non-injection drug users in China. The results showed that 
considerable proportions of sample reported engagement in risky sexual behaviors 
including: multiple sexual partners (37% of IDUs), concurrent sexual partnerships (46% 
of IDUs) and commercial sex partners (24% of IDUs). Only 42% of IDUs reported 
condom use with non-regular partners and 27% reported condom use with regular partner 
(Li et al., 2011). Unprotected sex was reported by 64% of research participants in a 
sample of 161 Pakistani IDUs (Altaf et al., 2007). The results of a survey done in 
Mauritius, an Indian Ocean Island revealed that among 511 IDUs, 61% reported injecting 
2-3 times/day and 29.3% reported past month injection with a previously used needle. 
Amongst the 60% of IDUs who reported having sexual intercourse in the past three 
months, 39.5% did so with ≥2 partners. Almost all IDUs (98.1%) reported inconsistent 
condom use in the past 12 months (Johnston, Saumtally, Corceal, Mahadoo, & Oodally, 
2011). CDC's National HIV Behavioral Surveillance System (NHBS) interviewed and 
tested 10,073 IDUs in 20 metropolitan statistical areas in 2009. Among the 9,565 IDUs 
with HIV-negative or unknown HIV status before the survey, 69% reported having 
unprotected vaginal sex, 34% reported sharing syringes, and 23% reported having 
unprotected heterosexual anal sex during the 12 previous months (CDC, 2009). 
The sex- and drug- related risk behaviors remain a driver of HIV, hepatitis C 
virus (HCV) and hepatitis B virus (HBV) transmission and other sexually transmitted 
diseases (STDs) throughout the world. In one study among the 407 IDUs recruited from a 
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region with higher incidence of STDs, HCV and HIV prevalence were 60.6% and 10.1%, 
respectively; and 98% of HIV positive individuals were co-infected with HCV (Pilon et 
al., 2011). While, HIV prevalence among 511 IDUs in Mauritius was 47.4%, HCV 
97.3%, HBV 9.0%, and syphilis 2.7%; and 99.7% of those infected with HIV were also 
infected with HCV (Johnston et al., 2011). In Puerto Rico, 255 young IDUs (16-24 years 
old) were evaluated regarding the factors associated with HIV-seropositivity. More than 
23% of subjects were HIV-seropositive (Marrero Rodriguez et al., 1993). 
HIV related risk behaviors and neurocognitive impairment: 
Once drug- and sex-related risk behaviors determined to be major 
transmission routes for HIV infection, identifying and understanding the reasons behind 
choosing drug- and sex-related risk behaviors among substance dependent individuals is 
crucial. Drug-related NCI reduces the individual's perception of personal risk and 
consequently is a significant barrier in managing risk behaviors. Lots of studies have 
shown that there is a mutual relationship between NCI and HIV related risk behaviors. 
Increased risk behaviors exacerbate NCI and NCI reduces the effectiveness of 
interventions aimed at reducing HIV related risk behaviors (Anand et al., 2010). Findings 
indicate that more intensive efforts may be required to reduce the risky behaviors among 
those IDUs with lower cognitive scores in higher risk social groups. On the other hand, 
risk-reduction interventions must consider the impact of NCI on learning and behavior 
(Anand et al., 2010).  
The results of 52 reviewed studies showed that HIV related risk behaviors 
were correlated with cognitive-behavioral factors, substance use, psychiatric illness, 
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childhood abuse, and social relationships. In these studies the majority of sexually active 
adults with severe mental illness were engaged in HIV related risk behaviors (such as 
unprotected sex, multiple sex partners, and injection drug use) (Meade & Sikkema, 
2005). One study evaluated the effects of implicit cognition, behavioral and personality 
variables (like poly-drug use and sensation seeking), on risky sexual behaviors (like lack 
of condom use, sex after drug use, and multiple sexual partners) among high risk and low 
risk adults from a community population. Results showed that the implicit cognition 
(unconscious influences such as knowledge, perception, or memory, that influence a 
person's behavior) was a significant, independent predictor of lack of condom use in the 
high-risk sample. Poly-drug use and sensation seeking (a personality trait common 
among drug users) also had important predictive effects (Stacy, Newcomb, & Ames, 
2000). Another study examined the effect of executive neurocognitive functions, 
sensation seeking, and HIV serostatus in predicting risky sexual practices among poly-
substance users (with a history of dependence primarily for cocaine or cocaine/heroin). 
The impact of executive functions was less clear but findings indicated that continued 
risk behavior among HIV infected drug users may be driven by sensation seeking 
(Gonzalez et al., 2005). One study in Baltimore examined the association among 
knowledge of someone who had died from AIDS, cognitive functioning, and drug and 
sex-related HIV risk behaviors among 229 IDUs of heroin. Among IDUs with lower 
cognitive scores, knowing someone who had died from AIDS was associated with 
increased risk and among IDUs with greater cognitive reserves, knowing someone who 
had died from AIDS was associated with decreased risk. This suggests that cognitive 
performance can provide protection to individuals in riskier social environments. These 
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findings can help in targeting HIV prevention efforts toward higher risk individuals 
within the IDU population (Mitchell, Severtson, & Latimer, 2007). 
 Behavioral interventions applied to reduce risk behavior in drug users 
There is currently no effective vaccine to prevent new HIV infections while 
previous studies show through behavioral interventions, risky sexual and needle sharing 
behaviors among IDUs can be reduced. Accordingly, behavioral interventions remain a 
primary tool for reducing the risk of HIV transmission (Semaan et al., 2002). Evidence 
shows that these behavioral interventions are applicable in a wide range of settings such 
as community based organizations that offer OAT for drug dependent patients. Margolin 
et al. (2003) randomly assigned 90 HIV-seropositive, methadone-maintained IDUs either 
to an experimental group receiving 12-session HHRP+ intervention or to a control group 
receiving harm reduction components recommended by the National AIDS 
Demonstration Research Project. Participants in experimental group received information 
on antiretroviral medication adherence and also received training on harm reduction 
skills, such as how to properly use condoms and how to sterilize needles. Subjects were 
followed at 6 and 9 months after the intervention. Reduction in risk behaviors was seen in 
both groups. However, patients receiving HHRP+ were less likely to use illicit opiates 
during intervention. Moreover, participants in experimental group showed lower 
addiction severity scores and less high-risk behaviors at follow up points (M. M. 
Copenhaver et al., 2007; Margolin et al., 2003). Avants et al. (2004) focused on 220 HIV-
negative methadone-maintained IDUs. Participants in the control group received standard 
care which involved 2 hours of counseling per month and a single-session risk reduction 
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intervention and experimental group’s participants received standard care plus 12-session 
HHRP intervention. The goal of the HHRP intervention was to promote health and 
increase quality of life through HIV prevention information, motivation to engage in HIV 
prevention and opportunities to practice behavioral skills for HIV prevention. Results 
indicated that experimental group’s participants were more likely to be abstinent from 
cocaine and to report fewer unsafe sexual practices (Avants et al., 2004).   
Because further evidence showed that 12-session HHRP intervention was very 
lengthy, complex, and costly in terms of training, implementation, and monitoring, 
Copenhaver et al. (2007) reduced the content and duration of HHRP intervention. The 
resulting intervention was a shortened, adapted version called the Community-friendly 
Health Recovery Program (CHRP) since it was designed to be more acceptable within the 
clinical context of community-based organizations. In this study, 226 HIV-negative 
methadone-maintained IDUs received 4-session CHRP intervention in an uncontrolled 
condition. Post-test results showed significant reductions in drug-and sex-related HIV 
risk behaviors. Moreover, the CHRP intervention demonstrated the potential to be fully 
integrated within drug treatment community based organizations (M. M. Copenhaver et 
al., 2007). Another study done in California compared a 4-month enhanced intervention 
(consist of nine sessions of HIV counseling, and testing) to a 2-session standard 
counseling and testing intervention developed by NIDA. The purpose of the study was to 
determine the efficacy of two different types of intervention in terms of reducing drug- 
and sex-related risk behaviors among IDUs. For both interventions, most risk behaviors 
were significantly reduced but enhanced intervention significantly increased IDUs’ use of 
their own injection equipment. According to these results, the theory-based cognitive-
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behavioral intervention showed limited advantage over the standard intervention in terms 
of both magnitude and frequency of HIV risk reduction achieved by high-risk drug users 
(Hershberger, Wood, & Fisher, 2003). 
Based on the previous information, risk-reduction behavioral interventions 
available for neurocognitively-impaired drug-involved people must consider the impact 
of NCI on learning and behavior. Some interventions provide cognitive remediation 
delivery strategies which are designed to take into account the possibility of NIC in the 
target populations and accordingly accommodate the specific intervention needs of drug 
users with NCI during intervention delivery (M. Copenhaver et al., 2003). Some of the 
cognitive remediation strategies thought to accommodate intervention participants with 
NCI include: training front-line clinical staff, especially addiction counselors to identify 
NCI, to communicate effectively with other health care providers and with 
neurocognitively-impaired clients, and to establish a trusting relationship with the client. 
The cognitive remediation strategies include developing a treatment plan, multimodal 
presentation of material (visual and verbal), experimental learning (practice, role-play, 
and behavioral games), use of simple language, frequent review of material, assessment 
with immediate feedback (observation of behavior and quizzes), having structured 
sessions and consistent times/locations, use of memory aids and stress management (M. 
Copenhaver et al., 2003).  
Both the HHRP and CHRP interventions are based on the Information–
Motivation–Behavioral Skills model of health behavior (Fisher & Fisher, 1992) which 
specifies that HIV prevention Information, Motivation, and Behavioral Skills are the 
fundamental determinants of HIV risk and HIV risk reduction behavior. From this 
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perspective, HIV prevention Information that is directly relevant to an individual’s 
practice of risk reduction behavior is a prerequisite for engaging in risk reduction action. 
Similarly, HIV prevention Motivation to act on what one knows about HIV prevention - 
including personal motivation (attitudes about personally taking preventive actions) and 
social motivation (perceived social support/social pressure to take preventive actions) - is 
an additional prerequisite for the initiating and maintaining HIV risk reduction behavior. 
Finally, HIV prevention behavioral skills for taking HIV preventive actions are a third 
prerequisite for engaging in HIV risk reduction behavior, and determine whether even a 
well-informed and well-motivated individual is able to skillfully initiate and maintain 
HIV risk reduction behavior (see Figure below). 
 
Figure 3: IMB MODEL 
 
Examples of drug- and sex-related HIV-risk reduction knowledge are “If an 
HIV positive person only has sex with another HIV positive person, they don’t need to 
use condom.” and ‘‘If an HIV positive person shared needles with another HIV positive 
person, they don’t need to clean the needles.’’ Examples of drug use personal and social 
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motivation incorporated in the CHRP intervention are “in the next 6 months do you plan 
(intend) to stop using heroine completely?” and “how important is being drug free to 
most of the people in your social network?” Examples of sex risk self-efficacy and 
reported behavior questions are “how confident are you that you would bring up the issue 
of condoms or safer sex in a conversation when sober” and “how many sexual partners 
have you had in the past 30 days?” 
Based on research to date, access to proven risk reduction behavioral 
interventions, and also continued research activities to develop optimal interventions for 
high risk population in the U.S. is crucial. The purpose of the current study was to 
examine NCI in a sample of HIV-negative methadone-maintained patients participating 
in an HIV prevention intervention study and to explore the association between NCI and 
HIV risk reduction intervention outcomes. The subjects were participants in a NIH-
funded randomized controlled trial testing the CHRP for HIV-negative drug users 
participating in drug treatment in New Haven, Connecticut. 
 
OBJECTIVES AND HYPOTHESIS 
Objective:  
1‐To examine whether there is a significant association between neurocognitive 
impairment and HIV risk reduction intervention outcomes among high‐risk HIV‐negative 
drug users seeking drug treatment in a community based methadone program.  
Hypothesis:  
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H1: There is a significant association between neurocognitive impairment and HIV risk 
reduction intervention outcomes among high‐risk HIV‐negative drug users seeking drug 
treatment in a community based methadone program. 
METHOD 
Design: It should be noted that the parent study was a randomized clinical 
trial of a community-friendly HIV-risk reduction behavioral intervention designed to 
reduce HIV risk behavior among high risk drug dependent individuals who were in drug 
treatment. The current study was a secondary analysis of a subset of data collected from 
the parent study. Specifically, correlational analysis was used to evaluate the association 
between HIV risk reduction intervention outcomes and NCI measured using the 
neuropsychological impairment scale (NIS) (O'Donnell, Reynolds, & De Soto, 1983). 
Participants: Two hundred and eighty high-risk HIV-negative opioid 
dependent drug users who were receiving MMT in a community based organization 
located in New Haven, Connecticut were recruited. Forty six percent of participants were 
male and a majority of them were Caucasian (73.9%), never married (65.7%), English 
speaking (94.6%), had a significant other (70%), with a median age of 33, and with 12 
years of education. From those who recruited first, 178 remained until the end of the 
study. There was no significant difference between the demographic characteristics of 
those who remained in the study with those who first were recruited (p> .30). Participants 
reported having a similar numbers of children (median = 1, p = .36) and had similar rates 
of living with their children (27.5%, p = .46). 
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High-risk opioid dependent drug users were defined as those patients who 
reported having unprotected sex or sharing needles (or other unsterilized injection 
equipment) within the past 6 months.  
Inclusion and exclusion criteria for this study were: being at least 18 years of 
age, meeting DSM‐IV criteria for opioid‐dependence, seeking MMT, reporting drug‐ or 
sex‐related HIV risk behavior in the previous 6 months, being able to read and 
understand the audio computer assisted self‐interview (ACASI) questions, being 
available for the full duration of the study with no anticipated participation limitation and 
not being actively suicidal, homicidal, or psychotic.  Informed consent was obtained from 
participants and any potential risks to confidentiality were explained to them. 
Procedure: Participants were randomly assigned to either the CHRP 
intervention group (n=136, 63 males) or the active control group (n=144, 66 males). Until 
the end of the study, only 87 participants remained in the intervention group and 91 
participants remained in the control group. Participants in the intervention group received 
standard of care plus four 45‐minute weekly group‐sessions of CHRP intervention and 
participants in control group received standard of care plus a time‐ and attention‐matched 
control condition that focused on social support.  
Study Groups: Subjects in the experimental condition participated in the 
CHRP intervention, which is a manual‐guided and adapted behavioral intervention for 
optimal use within drug treatment community based organizations. The CHRP 
intervention sessions consisted of general information on HIV/AIDS and HIV-related risk 
behaviors. Participants were also taught harm reduction skills, such as how to properly 
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use male and female condoms and how to properly sterilize needles. The intervention 
content was delivered by two trained bachelor’s level facilitators using cognitive 
remediation strategies designed to accommodate the mild to moderate cognitive 
difficulties that are common among this population (M. Copenhaver et al., 2003). The 
sessions were held at the APT Foundation’s methadone maintenance program in New 
Haven, CT.  
Subjects in the control condition participated in standard of care group 
meetings, which addressed psychological service needs (e.g., housing, employment and 
childcare) and referral resources in the community.  
Measures: Assessments of participants were done at baseline, immediately 
post‐intervention, and at 3‐, 6‐, and 12‐month post‐intervention follow‐up points through 
ACASI. Regarding self‐reported drug‐ and sex‐related HIV risk behavior, HIV/AIDS 
knowledge, risk reduction motivation and risk reduction behavioral skills were framed by 
the IMB skill model of health behavior change (Fisher & Fisher, 1992). Based on the 
IMB model of health behavior change, upon which the CHRP intervention is based, 
participants completed an assessment that covered the following domains: drug- and sex-
related HIV-risk reduction knowledge (Information component), personal and social 
motivation to reduce HIV risk behavior (Motivation component), and self-efficacy about 
reducing HIV risk behavior (Behavioral skills component). Four items were used to 
assess knowledge about safer sex and safer injection drug use (e.g., “If an HIV+ person 
shared needles with another HIV+ person, they don’t need to clean the needles.’’). Six 
items examined participants’ motivation to use condoms and clean needles, intentions to 
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engage in safer sexual activity and safer injection drug use practices, and their perception 
of significant others’ beliefs about the importance of using condoms and using clean 
needles (e.g., “in the next 6 months do you plan to stop using heroine completely?” for 
measuring the personal motivation component). Four items assessed participants’ 
behavioral skills in the form of their self-efficacy about abstaining from sexual activity 
and using a condom and about abstaining from injecting drugs and using clean needles  
(e.g., “how confident are you that you would bring up the issue of condoms or safer sex 
in a conversation when sober” for measuring Behavioral skills component). This 
assessment approach has been used in a randomized controlled trial of an evidence-based 
intervention (Fisher et al., 2004, M. M. Copenhaver et al., 2007) in order to inform 
intervention clinicians about HIV-related information, motivation, and behavioral skills 
deficits among participants entering treatment. 
The NIS was also completed at the same assessment points. The NIS is a 
95‐item self‐report questionnaire (O'Donnell et al., 1983) used to measure NCI. 
Participants responded to each item using a 5‐point response scale (0= not at all to 4= 
extremely). The NIS includes 7 subscale scores and 3 summary scores, which were 
computed, based on participant responses. There are also four validity checks contained 
in the NIS. The NIS is generally used as a screening instrument and not a diagnostic tool. 
This assessment instrument has been written at a fifth-grade reading level and the 
respondents have to be at least 18 years of age. Evidence shows that the sensitivity of 
NIS is 91% and its specificity is 76% using the Halstead Impairment Index (HII), which 
is a standard, more comprehensive neuropsychological battery (O'Donnell, De Soto, & 
Reynolds, 1984). 
  
26 
 
 
The NIS subscales which show impairment in the different cognitive domains including:  
1-Critical Items (CRIT): Assesses the patient’s history of neurological illness or injury. 
2-Cognitive Efficiency (COG): Assesses general symptoms of NCI. 
3-Attention (ATT): Assesses the patient’s ability to pay attention and concentrate. 
4-Memory (MEM): Assesses the patient’s memory. 
 5-Frustration Tolerance (FRU): Assesses irritability, anger and temper. 
6- Learning Verbal (LV): Assesses learning and expressive speech. 
7-Academic Skills (ACD): Assesses ability to carry out daily activities involving 
computing and reading. 
Summary scores which are designed to evaluate overall cognitive functioning 
include:  
1-Global Measure of Impairment (GMI) which provides an overall measure of 
impairment is calculated through total of responses to 80 items on the instrument 
(excluding Defensiveness Scale and Affective Disturbance items). 
2-Total Items Circled (TIC) is defined as total number of items with non-zero responses 
(excluding Defensiveness Scale and Affective Disturbance items). 
3-Symptom Intensity Measure (SIM) is computed by dividing the GMI by the TIC. 
NIS scores are usually expressed as T-scores. T-scores are standardized scores 
on each dimension for each type. A score of 50 represents the mean. A difference of 10 
from the mean indicates a difference of one standard deviation (SD). Thus, a score of 60 
is one standard deviation above the mean, while a score of 30 is two standard deviations 
below the mean. High levels in any of these scores indicate NCI but low scores can also 
indicate problems. For the purpose of this study NIS scores <30T were considered low, 
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scores >30T and <50T were considered average, a high score was >50T and < 60T, and 
any score above 60T was considered very high. 
The validity scores, which provide a foundation for the interpretation of the 
other scores, include:  
1-Defensiveness (DEF): Indicates the test takers attitude. 
2-Affective Disturbance (AFF): Indicates emotional state of the subject at the time of the 
test. 
3- Response Inconsistency (INC): Identifies inconsistent response pairs. 
4- The Subjective Distortion Check: tells whether the client is under- or over-reporting 
symptoms. 
Twice weekly urine toxicology screens were also taken from participants 
during the 4‐week intervention period. Urine toxicology screens differentiated between 
methadone and other opioids and showed the degree to which participants were still using 
illicit drugs including opiates and cocaine during the intervention period. In addition, a 
weekly self-report of illicit drug use and other high risk behaviors was obtained, which 
included self-reported: (a) quantity, frequency, and route of administration of illicit drugs, 
including heroin and cocaine; (b) frequency and type of other HIV risk behaviors, 
including needle sharing, unsafe needle cleaning, and unsafe sexual practices, and (c) 
frequency of harm reduction practices, such as use of needle exchange programs and 
purchase of needles and condoms. In addition, following each risk reduction group 
session, a quiz was administered to assess acquisition of intervention content. 
All subjects were reimbursed for the time and effort needed to participate in 
the study. They were paid $50 for each assessment session (at pre-intervention, post-
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intervention, and at a 3-, 6-, and 12-month post-intervention follow-ups) and $10 weekly 
for brief weekly assessments of substance use and HIV risk behaviors during the four 
week intervention phase. 
                    Data Analysis: Data from pre-intervention and post‐intervention were 
included in the secondary analysis. Simple correlations were carried out between all NIS 
scale and subscale scores (described above) and treatment outcome scores. P values were 
set at <.001, <.01 and <.05 and SPSS software was used for all statistical analyses. 
RESULTS 
Overall, outcomes of the parent study showed significant differences between 
the intervention and control groups with regard to key drug-risk reduction (i.e., safer drug 
use behavior, improved drug-risk reduction skills) and sex-risk reduction (i.e., obtaining 
condoms, self-efficacy in using condoms) variables. Support was also found for the IMB 
model of health behavior change. Participants in the CHRP group showed significantly 
improved HIV risk reduction outcomes in terms of changes in demonstrated sex- and 
drug-risk reduction (i.e., male and female condom application and properly cleaning 
injection equipment) versus those in the control group.  
There were no significant differences between the control and intervention 
group participants with regard to drug use or drug risk behavior while enrolled in the 
study. With regard to the NIS scores, the results of the current study show that there was 
no significant difference between the NIS scores of intervention and control groups from 
pre- to post-intervention. The NIS scores ranged from approximately 40T (1 SD below 
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the mean) on the symptom intensity measure subscale to 57T (0.8 SD above the mean) 
for affective disturbance subscales.  
Significant differences were found between NIS scores of male and female 
participants. Females showed higher scores in global measure of impairment (GMI) - 
indicating greater overall NCI- compared to males. Females also showed higher scores in 
subscales of affective disturbance, cognitive efficiency, attention, frustration tolerance, 
and academic skills (Table 1). 
 
 Control  Intervention Gender 
Predictor Mean SE Mean SE     Male  
 
Female  
 
Validity Scores       
- Response Inconsistency 53.29 .71 52.29 .73 52.01 53.58 
- Defensiveness Scale 39.61 .52 40.34 .53 39.86 40.09 
- Affective Disturbance 57.79 .82 57.45 .83 55.38*** 59.87*** 
       
Summary Scores       
- Global Measure 55.07 0.98 55.33 1.00 52.77*** 57.63*** 
- Total Items Circled       
- Symptom Intensity Measure 39.12 0.90 40.78 0.91 38.81 41.09 
       
Impairment Subscales       
- Critical Items 56.55 0.93 56.25 0.95 55.45 57.34 
- Cognitive Efficiency 53.75 0.90 55.23 0.92 52.54** 56.53** 
- Attention 54.67 0.96 54.67 0.98 51.86*** 57.47*** 
- Memory 52.48 0.95 52.46 0.97 51.32 53.62 
- Frustration Tolerance 57.39 0.86 56.84 0.87 54.90*** 59.33*** 
- Learning-Verbal 51.59 0.92 52.46 0.93 51.47 52.58 
- Academic Skills 53.40 0.90 53.24 0.91 51.46** 55.18** 
Table1. Descriptive results of NIS scale (*p<.05; **p<.01; ***p<.001) 
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Importantly, the analyses also indicated that intervention group participants with 
higher levels of NCI tended to benefit less from the intervention content in terms of: (1) 
learning drug-risk reduction skills (i.e., safer drug use behavior, improved drug-risk 
reduction skills) and (2) learning sex-risk reduction skills (i.e., obtaining condoms, self-
efficacy in using condoms) that were taught during the group sessions compared with 
participants with lower levels of cognitive impairment.  HIV risk reduction skills were 
not taught in the control group sessions and – as might be expected - this pattern of 
associations was not observed among control group participants.   
For the intervention group, negative relationships were found between most of 
NIS subscales and improvement in drug-risk reduction skills from pre- to post-
intervention compared to those in the control group. This pattern of results indicates that 
higher scores on the NIS subscales were significantly associated with less improvement 
in drug-risk reduction skills. For the intervention group, higher scores on the global 
measure of impairment – indicating greater overall NCI – were associated with less 
improvement in drug-risk reduction skills from pre- to post-intervention compared with 
those in the control group. The same results were seen with regard to subscales of 
cognitive efficiency, attention, memory, frustration tolerance; learning-verbal, academic 
skill, affective disturbance, and symptom intensity measure (see table2). 
 For the control group, higher scores on the global measure of impairment – 
indicating greater overall NCI – were associated with less reported drug use from Pre to 
Post compared with those in the intervention group. The same results were seen with 
regard to subscales of cognitive efficiency, response inconsistency, critical items, 
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attention, frustration tolerance; learning-verbal, academic skill, affective disturbance, and 
symptom intensity measure (Table 2).  
NIS items Social 
motivatio
n 
Knowledg
e 
Drug RR Skills Drug 
informati
on 
Drug use Self-
esteem 
Personal 
motivation 
Validity 
Scores: 
       
Response 
Inconsistency 
    x/-.30***   
Defensiveness 
Scale 
  x / x -.16+/x  x /-.18* x /-.14+ 
Affective 
Disturbance 
  -.22** / x  x / -.23**   
        
Summary 
Scores: 
       
Global 
Measure 
  -.19* / x  x / -.24**   
Total Items 
Circled 
       
Symptom 
Intensity 
Measure 
  -.20* / x  -.16+ / -.20* x / .17*  
        
Impairment 
Subscales: 
       
Critical Items     x/ -.29***   
Cognitive 
Efficiency 
  -.23** / x  x / -.20*   
Attention   -.15+ / x  x / -.18*   
Memory   -.19* / x     
Frustration 
Tolerance 
  -.17+ / x  -.15+ / -.19*   
Learning-
Verbal 
  -.24**/-.18*  -.24**/-.18*   
Academic 
Skills 
  -.15+ / x  x / -.21*   
Table2. Significant associations between NIS scores and drug-risk reduction skills from 
pre to post intervention (intervention / control). *p<.05; **p<.01; ***p<.001 
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For the intervention group, higher scores on the global measure of impairment 
– indicating greater overall NCI – were associated with less sex risk reduction (condom 
use) from pre- to post-intervention compared with those in the control group. The same 
results were seen with regard to subscales of cognitive efficiency, critical items, memory, 
academic skill, and symptom intensity measure (Table 3). 
NIS items Social 
motivation 
Knowledge Self-esteem Purchasing 
condoms 
Safe sex 
Validity 
Scores: 
     
Response 
Inconsistency 
   x / .15+ x / .18* 
Defensiveness 
Scale 
   -.28** / x x / -.16+ 
Affective 
Disturbance 
   x / .18*  
      
Summary 
Scores: 
     
Global 
Measure 
   -.18+ / x  
Total Items 
Circled 
     
Symptom 
Intensity 
Measure 
   -.29** / x  
      
Impairment 
Subscales: 
     
Critical Items    -.19* / x  
Cognitive 
Efficiency 
   -.17+ / x  
Attention      
Memory    -.22* / x  
Frustration 
Tolerance 
   x / .19*  
Learning-
Verbal 
     
Academic 
Skills 
   -.20* / x  
Table3. Significant associations between NIS scores and sex-risk reduction skills from 
pre to post intervention (intervention / control). *p<.05; **p<.01; ***p<.001 
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Discussion 
 
 
The parent study provided evidence of efficacy of the CHRP intervention, as 
significant enhancements were demonstrated in participants’ behaviors including 
participants’ demonstration of drug- and sex-related HIV risk reduction skills. Consistent 
with other studies with this target population of HIV-negative chronic drug users 
indicating deficits in different tasks of neuropsychological tests (Rapeli et al., 2006; 
Gould, 2010; Gillen et al., 1998; Fernandez-Serrano et al., 2010; Fishbein et al., 2007) in 
the current study, also moderate to severe cognitive impairment was evident among the 
participants as indicated by generally low scores on the NIS as well as relatively lower 
scores across specific subscales.  The current study appears to be the first study assessing 
the potential association between neurocognitive impairment with risk reduction 
intervention outcomes among HIV-negative chronic drug users. Following the 
intervention, improvements in drug- and sex-related HIV risk reduction outcomes were 
negatively associated with NCI among the intervention group participants.   
The results of the current study also show that there is no significant 
difference between the intervention and control groups with regard to the NCI from pre- 
to post-intervention. This finding supports the concept of positive effects stemming from 
behavioral interventions in terms of reducing HIV risk behaviors. As this effect was not 
seen among the control group participants knowing that the only difference between 
control and intervention groups participants was in having access to the intervention 
content, therefore, the results of the parent study regarding the efficacy of the CHRP 
intervention is strongly supported as those participants with lower levels of NCI who 
specifically receive the CHRP intervention demonstrate more HIV risk reduction skill 
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development while, less improvement from the intervention content was seen among the 
intervention group participants with higher levels of NCI.  
On the other hand, NCI was associated with lower self-efficacy not involving 
in drug and sex related risk behaviors and more difficulty learning drug- and sex-risk 
reduction skills. For example, participants with higher NCI showed less sex-risk 
reduction (purchased condoms less frequently) and showed less improvement in drug-risk 
reduction skills.  
Type of variable    Constructs 
Drug use Information 
Personal motivation, Social motivation 
Self-efficacy/difficulty, Reported behavior   
Sex behavior   Information 
Personal motivation, Social motivation 
Self-efficacy/difficulty, Reported behavior   
Table 4: Variables used and IMB constructs 
Moreover, looking at validity scores of NIS, the mean value for defensiveness 
suggests that participants did not have a wrong attitude towards the test. On the other 
hand, the mean affective disturbance score was suggestive of some degree of emotional 
stress at the time of the test which was not a surprising finding considering the nature of 
the sample and the fact that drug involved individuals are typically socio-economically 
disadvantaged. The mean response inconsistency score also indicates some inconsistent 
answers to questions on the NIS. 
The current study had a number of limitations. First, the sample size included 
in this secondary analysis was small. It was not sufficiently large to generate enough 
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power in the statistical analyses to adequately examine all the variables of interest. And it 
is strongly recommended for future studies to evaluate a larger number of HIV-negative 
drug involved patients with more complex analytical tests. Secondly, the NIS does not 
provide a comprehensive assessment of NCI and does not measure all possible cognitive 
domains although it is a very user-friendly test. Thirdly, the components of IMB skill 
model of health behavior change are highly correlated with one another and also the 
questions used for assessing each component could be understandable for a group of 
people while at the same time they could be misleading for some other participants. It is 
possible that, with a larger sample, a multivariate analysis could be carried out which 
would allow us to control for such associations. Fourthly, almost all data were provided 
through self-report assessments, and self-reported assessments are always a challenge to 
the integrity of the responses provided, especially because the study seeks to examine 
mostly socially unacceptable behaviors. This may have been moderated, however, by the 
use of ACASI systems, which provided participants with a high level of privacy in 
addition to the assurance of anonymity. Finally, subjects with poor scores on the validity 
checks score (e.g. defensiveness, affective disturbance and response inconsistency) 
should have been excluded from this analysis for more accurate interpretation of results. 
However, already having a relatively small sample size would have further reduced 
statistical power.  
There was also an unexpected pattern of outcomes to find that, for the control 
group, reported drug use was negatively associated with NCI from pre- to post-
intervention compared with those in the intervention group. This indicates that 
participants in the control group with higher NCI tended to report less drug use. This 
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pattern of association was not seen among intervention group participants. The control 
group participants received more information focused on drug prevention and treatment 
which could explain why this pattern of association was only seen among control group 
participants. But, this finding is surprising as we had hypothesized that better HIV risk 
reduction intervention outcomes such as less drug use would be observed in participants 
with lower NCI.  In fact, participants with higher NCI have been found to show more 
improvements. 
 This puzzling finding could have happened as a result of some possible 
confounding factors that correlate with both the NCI and different items of IMB skill 
model of health behavior change and subsequently these confounding factors could cause 
surprising results. In the current study we tried to control for some of these confounding 
variables as the results show that there were no significant differences between the 
control and intervention group participants with regard to drug use or drug risk behavior 
while enrolled in the study.  However, due to the inability to control for variability of 
human studies, confounding is a particular challenge and for future studies, it is important 
to control for some more important confounding variables like alcohol dependency to 
isolate the effect of NCI on HIV risk reduction intervention outcomes. For these reasons, 
future studies could also offer to test confounders in a complex mixed effects or structural 
equation model. For example it is recommended to test different components of IMB skill 
model of health behavior change (information, motivation and behavioral skills) among 
control and intervention group participants with lower and higher NCI. 
As NCI apparently has an important role on intervention outcomes targeting 
sex- and drug-related risk behaviors and considering that these interventions typically 
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place a high demand on several cognitive domains such as memory, learning, and 
attention so, NCI may be a potential confounding variable with regard to treatment 
outcomes. Adequate attention should be paid to NCI when designing and implementing 
interventions for this population like what Copenhaver et al. done in their study in 2003. 
This is particularly important where NCI symptoms are mostly mild and can very easily 
be ignored or be mistaken for other effects of active drug use such as hangovers or being 
‘high’. 
 
Conclusion 
 
 
               Results of this study suggest that screening for NCI in this population, and 
potentially accommodating mild to moderate levels of NCI in the delivery of 
interventions maybe helpful to be applied in all future behavioral risk reduction 
interventions for this target population as implied in prior work (Copenhaver et al., 2003). 
Moreover, controlling for confounding factors that correlate NCI may provide more 
accurate interpretation of study results among this patient population. It may also be 
necessary to assess the associations of NCI and intervention outcome variables at follow 
up points. NCI may account for drop outs and may also explain some of the relapse often 
experienced in behavioral interventions. Moreover, future studies should use more 
comprehensive and sensitive screening instruments for NCI and also increase the sample 
size and objectively assess the contributions of cognitive remediation strategies. On the 
other hand, greater NCI in female participants compared to male participants was an 
unexpected result and it is recommended that future studies utilize a larger sample, to 
assess the possible relationship between gender and greater NCI. Relatively high scores 
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on affective disturbance observed were not unexpected in this sample considering the 
social and economic challenges faced by this population. It however suggests that those 
who administer neuropsychological test ought to be careful not to have activities that 
could add any more emotional strain to participants coinciding with test taking as this 
could potentially affect the reliability of test results. Although the CHRP intervention has 
been shown to be efficacious in this target population of HIV-negative chronic drug 
users, such interventions may not be the first line of treatment for patients with cognitive 
difficulties, and it may still be necessary to explore other intervention approaches to 
improve sex- and drug-related risk behaviors in this population. Substance use treatment 
such as methadone maintenance treatment has been shown to play a helpful role to 
address drug risk behavior. This study also suggests that there could be sub groups of 
patients within the larger group of HIV-negative chronic drug users based on 
neurocognitive status. Recognizing this and tailoring treatment to meet their needs seems 
to be valuable in order to have an effective intervention targeting this population. 
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